MYNZ
NASDAQ
$1.16
Mainz Biomed N.V. (MYNZ)
Sector:
Healthcare
Industry:
Diagnostics & Research
Market Cap
$12M
Free Cash Flow Yield
-91.28%
Price Chart
Valuation
Market Cap$12M
Profitability
Total Revenue (TTM)$537K
Gross Profit (TTM)$445K
EBITDA-$16M
EPS-$1.66
Financial Health
Free Cash Flow Yield-91.28%
Growth & Risk
Revenue 5Y CAGR-1.44%
Sharpe Ratio0.54